“[Boehringer Ingelheim] had little incentive to investigate the dangers in a product that was producing over $1 billion in ...

Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...

A new nationwide recall has been issued for a generic version of the heartburn and ulcer drug Zantac due to the potential presence of an impurity that could cause cancer. It's the fourth recall for ...

WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...

Apotex Corp. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) to the Retail level. Apotex has learned from the U.S. Food and Drug ...